Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/10/2022* -- Results Q2 2022 -- 0.58 --
08/10/2022* 08:30 EST Earnings Call Q2 2022 -- -- --
05/03/2022 -- Results Q1 2022 0.35 0.42 -15.66%
05/03/2022 08:30 EST Earnings Call Q1 2022 -- -- --
02/28/2022 -- Results Q4 2021 0.63 0.51 23.53%
02/28/2022 08:30 EST Earnings Call Q4 2021 -- -- --
11/09/2021 -- Results Q3 2021 -0.17 0.52 -132.7%
11/09/2021 08:30 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/10/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/03/2022
Beat/Miss Upgrade
Return Since 11.16%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
URL https://www.harmonybiosciences.com
Investor Relations URL https://ir.harmonybiosciences.com/
HQ State/Province Pennsylvania
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Aug. 10, 2022 (est.)
Last Earnings Release May. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
--
--
17.95%
-3.07%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.67%
32.33%
-32.38%
2.42%
-0.65%
0.53%
28.66%
30.72%
4.69%
166.6%
-28.90%
102.8%
96.14%
18.24%
32.12%
-47.18%
-21.01%
--
--
--
--
--
--
-79.67%
-72.61%
18.26%
38.41%
39.82%
14.52%
19.99%
21.20%
45.21%
-2.98%
As of May 20, 2022.

Profile

Edit
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
URL https://www.harmonybiosciences.com
Investor Relations URL https://ir.harmonybiosciences.com/
HQ State/Province Pennsylvania
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Aug. 10, 2022 (est.)
Last Earnings Release May. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
F00001CY0Z 612.00 USD 6.12%
F00001DM9R 332.00 USD 3.32%
BBP 348949.0 USD 2.61%
ADVGX 619071.0 USD 2.53%
RHJMX 382840.0 USD 2.45%
PFACX 349826.0 USD 1.75%
XPH 2.162M USD 1.16%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter HRMY Tweets